A biopharmaceutical business for patients with rare diseases, Orchard Therapeutics partners with the likes of Great Ormond Street Hospital and University College London.

With offices in the UK and US, it develops innovative gene therapies and has raised $280m funding.

Back to BusinessCloud's 101 HealthTech Innovators